Paper · 305458
Genetic restrictions for the induction of suppressor T cells by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity. Role of the H-2D region of the major histocompatibility complex.
Miller SD and 2 others. J Exp Med, 1978. Cited by 67 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genetic restrictions for the induction of suppressor T cells by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity. Role of the H-2D region of the major histocompatibility complex. Papers, record 305458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/305458
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Genetic restrictions for the induction of suppressor T cells by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity. Role of the H-2D region of the major histocompatibility complex.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dinitrofluorobenzene | Major topic |
| H-2 Antigens | Major topic |
| Immunity, Cellular | Major topic |
| Immunosuppression Therapy | Major topic |
| Nitrobenzenes | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Chromosome Mapping | |
| Dermatitis, Contact | |
| Dinitrobenzenes | |
| Haptens | |
| Immune Tolerance | |
| Mice |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 302,178 | Genetic restriction in T-lymphocyte activation by antigen-pulse peritoneal exudate cells. | Cold Spring Harb Symp Quant Biol | 1977 | https://conductscience.org/library/papers/302178 | PubMed |
| 2 | 300,292 | Tolerance and contact sensitivity to DNFB in mice. VII. Functional demonstration of cell-associated tolerogen in lymph node cell populations containing specific suppressor cells. | Cell Immunol | 1977 | https://conductscience.org/library/papers/300292 | PubMed |
| 3 | 300,774 | H-2 restriction of suppressor T-cell induction by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitization. | J Exp Med | 1977 | https://conductscience.org/library/papers/300774 | PubMed |
| 4 | 301,091 | The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. | Eur J Immunol | 1977 | https://conductscience.org/library/papers/301091 | PubMed |
| 5 | 299,922 | H-2 compatibility requirements for T suppressor cell functions induced by Friend leukaemia virus. | Nature | 1977 | https://conductscience.org/library/papers/299922 | PubMed |
| 6 | 915,281 | Soluble factors in tolerance and contact sensitivity to DNFB in mice. II. Genetic requirements for suppression of contact sensitivity by soluble suppressor factor. | J Immunol | 1977 | https://conductscience.org/library/papers/915281 | PubMed |
| 7 | 874,422 | Suppressor cells in tolerance to contact sensitivity active against hapten-syngeneic and hapten-allogeneic determinants. | J Exp Med | 1977 | https://conductscience.org/library/papers/874422 | PubMed |
| 8 | 874,323 | Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. I. Suppression of contact sensitivity by soluble suppressor factor released in vitro by lymph node cell populations containing specific suppressor cells. | J Immunol | 1977 | https://conductscience.org/library/papers/874323 | PubMed |
| 9 | 1,087,316 | The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction. | J Immunol | 1976 | https://conductscience.org/library/papers/1087316 | PubMed |
| 10 | 1,085,418 | Separation of suppressor and killer T cells by surgace phenotype. | Nature | 1976 | https://conductscience.org/library/papers/1085418 | PubMed |
1 to 10 of 25
See all 25 referencesCited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,001,023 | Effect of murine interferon alpha/beta on tumour-induced suppressor function. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8001023 | PubMed |
| 7,203,554 | Analysis of neonatally induced tolerance of H-2 alloantigens. I. Adoptive transfer indicates that tolerance of class I and class II antigens is maintained by distinct mechanisms. | Immunogenetics | 1981 | https://conductscience.org/library/papers/7203554 | PubMed |
| 6,449,479 | Suppression of the proliferative response to H-2D by I-J subregion gene products. | Immunogenetics | 1980 | https://conductscience.org/library/papers/6449479 | PubMed |
| 6,444,234 | Role of self carriers in the immune response and tolerance. V. Reversal of trinitrophenyl-modified self suppression of the B-cell response by blocking of H-2 antigens. | J Exp Med | 1980 | https://conductscience.org/library/papers/6444234 | PubMed |
| 6,242,890 | Serological detection of H-2K- and H-2D-gene products. I. Principal difference between T and B lymphocytes in expression of H-2D-encoded alloantigens. | Immunogenetics | 1980 | https://conductscience.org/library/papers/6242890 | PubMed |
| 6,214,508 | Genetic regulation of the antibody response to H-2Db alloantigens in mice. V. Control by several genes of the H-2 complex in mice of the C57BL/10 background. | Immunogenetics | 1982 | https://conductscience.org/library/papers/6214508 | PubMed |
| 6,193,239 | An antigen-specific signal is required for the activation of second-order suppressor T cells in the regulation of delayed-type hypersensitivity to 2,4,6-trinitrobenzene sulfonic acid. | J Exp Med | 1983 | https://conductscience.org/library/papers/6193239 | PubMed |
| 6,165,799 | Antigen- and receptor-driven regulatory mechanisms. VII. H-2-restricted anti-idiotypic suppressor factor from efferent suppressor T cells. | J Exp Med | 1981 | https://conductscience.org/library/papers/6165799 | PubMed |
| 3,785,166 | Regulated expression of a murine class I gene in transgenic mice. | Mol Cell Biol | 1986 | https://conductscience.org/library/papers/3785166 | PubMed |
| 3,159,824 | Tubular antigen-derivatized cells induce a disease-protective, antigen-specific, and idiotype-specific suppressor T cell network restricted by I-J and Igh-V in mice with experimental interstitial nephritis. | J Exp Med | 1985 | https://conductscience.org/library/papers/3159824 | PubMed |
1 to 10 of 13
See all 13 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/305458
GET https://conductscience.org/api/papers/v1/305458/references?page=2